The First Canine Influenza Vaccine Now Fully Licensed by the USDA

Press Release:
Intervet/Schering-Plough Animal Health is pleased to inform you that Canine Influenza Vaccine, H3N8 has been granted a full license by the USDA after a year of safe and effective use in close to half a million dogs. Now called Nobivac® Canine Flu H3N8, the vaccine has been proven to reduce the severity and spread of disease.

This action by the USDA acknowledges the ongoing need to protect dogs against canine influenza, a serious and potentially fatal disease, as outbreaks continue to occur. Since the first reported case in Florida in 2004,1 canine influenza virus (CIV) has been confirmed in 33 states, and it continues to spread.

Which dogs should be vaccinated against canine influenza?
Consider vaccinating any dog that interacts with other dogs at venues such as boarding facilities, doggie daycares, breeding facilities, or dog shows. In fact, all dogs that are vaccinated for Bordetella should be considered for CIV vaccination since these dogs are likely to come in contact with other dogs in closed environments. And, dogs of veterinary staff that may be exposed at home through contaminated fomites should also be vaccinated. Dogs have no natural immunity to CIV, so virtually all naive dogs will become infected. Highly contagious, canine influenza can rapidly infect a large number of dogs in these multi-dog settings.

Nobivac® Canine Flu H3N8 is only available from Intervet/Schering-Plough Animal Health, a company with a long history of expertise in veterinary influenza vaccine development.

For more information, please contact your veterinarian or visit www.doginfluenza.com.